-

Parthenon Capital Sells ScentAir

SAN FRANCISCO--(BUSINESS WIRE)--Parthenon Capital, a leading growth-oriented private equity firm, announced today that it sold its position in portfolio company ScentAir Holdings, Inc (“ScentAir” or the “Company”). The transaction represents the culmination of a successful five-year partnership with ScentAir’s management team, led by Chief Executive Officer Dan Connors. Mr. Connors and his team will continue to lead the company going forward. The private equity arm of CITIC Capital Holdings Limited (“CITIC Capital”) led the new investment in the Company.

Based in Charlotte, NC, ScentAir is the leading provider of scent marketing solutions to leading brands around the world. Currently servicing over 45,000 placements in 119 countries, ScentAir has been helping industry leaders create powerful customer experiences using fragrance for over 20 years.

Parthenon Capital initially invested in ScentAir in December 2014. Throughout the partnership, Parthenon Capital and management invested in the Company to transform the business into an industry leader, completing four acquisitions, introducing several new market-leading products, developing and growing its international salesforce, and expanding the team. “Dan and his team did a phenomenal job establishing ScentAir as the global industry leader in a market with tremendous white space and opportunity for continued growth. We have thoroughly enjoyed working alongside Dan and his team,” said Andrew Dodson, managing partner at Parthenon Capital. “We are proud of what we have accomplished together and wish the team all the best going forward.”

ScentAir CEO Dan Connors added, “On behalf of the management team at ScentAir, we’d like to thank Parthenon Capital for their effective sponsorship of our business these past five years. We’d also like to thank CITIC Capital for their confidence in our business and their sponsorship of us going forward. We feel very fortunate to enjoy relationships with great private equity firms such as these.”

ABOUT PARTHENON CAPITAL

Parthenon Capital is a leading mid-market private equity firm with offices in Boston, San Francisco and Austin. Parthenon utilizes niche industry expertise and a deep execution team to invest in growth companies in service and technology industries. Parthenon seeks to be an active and aligned partner to management, either through recapitalization transactions or by backing new executives. Parthenon has particular expertise in financial and insurance services, healthcare and business services, but seeks any service, technology or delivery business with a strong value proposition and proprietary know-how. For more information, please visit www.parthenoncapital.com.

ABOUT SCENTAIR

ScentAir Technologies, LLC., privately held and founded in 1994, provides best-in-class ambient scent marketing solutions to many of the world’s most recognized brands. As the global leader in olfactory marketing, the Company creates memorable impressions for both small businesses and global enterprises, elevating their customer experience through the power of scent. Based in Charlotte, NC, USA, and with corporate offices in the United Kingdom, France, Netherlands, China, Hong Kong, Japan, and Australia, the Company’s 425+ global team members service customers in 119 countries through its dedicated global supply chain and manufacturing operations in North America, Europe, and Asia. ScentAir is committed to the creation of customized scent strategies that boost clients’ brand sentiments, customer loyalty, and sales. To learn more, go to www.scentair.com.

Contacts

Molly Fazio Kloos, Parthenon Capital
617-960-4012
mollyk@parthenoncapital.com

Parthenon Capital


Release Versions

Contacts

Molly Fazio Kloos, Parthenon Capital
617-960-4012
mollyk@parthenoncapital.com

More News From Parthenon Capital

Elevate Patient Financial Solutions Announces Strategic Investment from Audax Private Equity and Parthenon Capital

SPRING, Texas--(BUSINESS WIRE)--Elevate Patient Financial Solutions (“Elevate” or the “Company”), a leading provider of front-end eligibility and enrollment and back-end revenue cycle management (“RCM”) technology and services, announced a strategic investment from Audax Private Equity (“Audax”) and Parthenon Capital (“Parthenon”), two private equity firms with a long history of supporting innovative healthcare businesses. The investment will provide Elevate with additional resources and capita...

Parthenon Capital Announces Strategic Growth Investment in Medical Review Institute of America

SALT LAKE CITY--(BUSINESS WIRE)--Medical Review Institute of America (“MRIoA” or the “Company”), a leading provider of outsourced utilization management and clinical review solutions to payers, announced a strategic investment from Parthenon Capital (“Parthenon”), a growth-oriented private equity firm. As part of the transaction, MRIoA management and Summit Partners, an investor in MRIoA since 2017, will both retain significant positions in the business. Financial terms were not disclosed. “We...

Parthenon Capital Sells Institutional Cash Distributors, a Leading Independent, Multi-Fund Investment Platform for Corporate Treasury Professionals, to Tradeweb Markets, Inc.

SAN FRANCISCO--(BUSINESS WIRE)--Parthenon Capital, a leading growth-oriented private equity firm, announced today the signing of a definitive agreement to sell Institutional Cash Distributors, LLC (“ICD”), an institutional investment software and technology provider for corporate treasury organizations trading short-term investments, to Tradeweb Markets, Inc. (NASDAQ: TW). The closing of the transaction is subject to customary conditions and regulatory approvals. Based in Golden, CO, the ICD po...
Back to Newsroom